| ESMO expert consensus statements on the screening and management of financial toxicity in patients with cancer PM Carrera, G Curigliano, D Santini, L Sharp, RJ Chan, M Pisu, F Perrone, ... ESMO open 9 (5), 102992, 2024 | 1 | 2024 |
| Revised European Association for Palliative Care (EAPC) recommended framework on palliative sedation: An international Delphi study SM Surges, H Brunsch, B Jaspers, K Apostolidis, A Cardone, C Centeno, ... Palliative Medicine, 02692163231220225, 2024 | 12 | 2024 |
| Essential cancer medicines: adding feasibility to the magnitude of clinical benefit value chain F Roitberg, T Amaral, NI Cherny, R Giuliani, NJ Latino, M Galotti, G Bricalli, ... ESMO open 8 (5), 101617, 2023 | | 2023 |
| ESMO-Magnitude of Clinical Benefit Scale for haematological malignancies (ESMO-MCBS: H) version 1.0 B Kiesewetter, U Dafni, EGE de Vries, J Barriuso, G Curigliano, ... Annals of Oncology 34 (9), 734-771, 2023 | 8 | 2023 |
| PB2707: ESMO-MAGNITUDE OF CLINICAL BENEFIT SCALE FOR HAEMATOLOGICAL MALIGNANCIES (ESMO-MCBS: H) VERSION 1.0 B Kiesewetter, U Dafni, EGE De Vries, J Barriuso, G Curigliano, ... HemaSphere 7 (S3), e02308e3, 2023 | | 2023 |
| Ethical considerations in the relief of cancer pain NI Cherny, B Ziff-Werman Supportive Care in Cancer 31 (7), 414, 2023 | 2 | 2023 |
| Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints in Cancer Clinical Trials-Innovative Medicines Initiative (SISAQOL-IMI … M Pe, A Alanya, RS Falk, CD Amdal, K Bjordal, J Chang, P Cislo, ... The Lancet Oncology 24 (6), e270-e283, 2023 | 9 | 2023 |
| Evaluation of the ESMO-Magnitude of Clinical Benefit Scale version 1.1 (ESMO-MCBS v1. 1) for adjuvant radiotherapy in breast cancer E Sapir, NI Cherny, RD Ennis, BD Smith, GL Smith, LB Marks, BW Corn ESMO open 8 (3), 101206, 2023 | 1 | 2023 |
| Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale (ESMO-MCBS) credit SF Oosting, J Barriuso, A Bottomley, M Galotti, B Gyawali, B Kiesewetter, ... Annals of Oncology 34 (4), 431-439, 2023 | 12 | 2023 |
| Off-label despite high-level evidence: a clinical practice review of commonly used off-patent cancer medicines G Zarkavelis, AL Amylidi, C Verbaanderd, NI Cherny, Y Metaxas, ... ESMO open 8 (1), 100604, 2023 | 8 | 2023 |
| Corrigendum to ‘Towards a novel approach guiding the decision-making process for anticancer treatment in patients with advanced cancer: framework for systemic anticancer … K Ribi, N Kalbermatten, M Eicher, F Strasser, J Arends, S Gonella, ... ESMO open 7 (6), 2022 | | 2022 |
| Feasibility of large-scale implementation of an electronic patient-reported outcome remote monitoring system for patients on active treatment at a community cancer center NI Cherny, CM Parrinello, L Kwiatkowsky, J Hunnicutt, T Beck, E Schaefer, ... JCO Oncology Practice 18 (12), e1918-e1926, 2022 | 8 | 2022 |
| Does the European Society of Medical Oncology-Magnitude of Clinical Benefit Scale (ESMO-MCBS v1. 1) Apply to Radiation Oncology? A Constructive Critique E Sapir, NI Cherny, RD Ennis, BD Smith, GL Smith, LB Marks, B Corn International Journal of Radiation Oncology, Biology, Physics 114 (3), e335, 2022 | | 2022 |
| Risk-adapted modulation through de-intensification of cancer treatments: an ESMO classification D Trapani, MA Franzoi, HJ Burstein, LA Carey, S Delaloge, N Harbeck, ... Annals of Oncology 33 (7), 702-712, 2022 | 31 | 2022 |
| An appraisal of FDA approvals for adult solid tumours in 2017–2021: has the eagle landed? NI Cherny Nature Reviews Clinical Oncology 19 (7), 486-492, 2022 | 24 | 2022 |
| ePRO-based digital symptom monitoring in a community oncology practice to reduce emergency room and inpatient utilization. MA Kolodziej, L Kwiatkowsky, C Parrinello, T Thurow, ES Schaefer, ... Journal of Clinical Oncology 40 (16_suppl), 1508-1508, 2022 | 4 | 2022 |
| “The first ones now, will later be last”: understanding the importance of historical context when reading ESMO-MCBS scores NI Cherny, U Dafni, G Pentheroudakis, M Piccart, P Zygoura, B Gyawali, ... ESMO open 7 (2), 2022 | | 2022 |
| Implementation of the ESMO-magnitude of clinical benefit scale: real world example from the 2022 Israeli National Reimbursement Process I Wolf, B Waissengrin, A Zer, R Bernstein-Molho, K Rouvinov, JE Cohen, ... ESMO open 7 (1), 2022 | 5 | 2022 |
| Prioritising systemic cancer therapies applying ESMO’s tools and other resources to assist in improving cancer care globally: the Kazakh experience NJ Latino, M Galotti, NI Cherny, EGE de Vries, JY Douillard, D Kaidarova, ... ESMO open 7 (1), 100362, 2022 | 11 | 2022 |
| Opioid therapy NI Cherny, MT Fallon Oxford Textbook of Palliative Medicine, 372, 2021 | | 2021 |
